FROM THE SOURCE Asia Beauty selected this report from Premium Beauty News for its relevance to the global beauty community.
The US biotech beauty company has launched a new active ingredient designed to reduce hyperpigmentation and brighten the skin at a recommended use level of 0.45%, positioning it as an alternative to higher-concentration legacy brightening ingredients. Dubbed DermCeutical PNar, Debut's new biotech active ingredient is designed to target hyperpigmentation through a molecular design approach that combines AI, skin genomics and biotechnology. According to the company, the ingredient works by...
This source briefing is indexed as part of Asia Beauty’s editorial discovery service. Read the original report for the complete reporting, context, quotations and any subsequent updates.
READ THE ORIGINAL ARTICLEPremium Beauty News ↗SOURCE
Original publication details
- Publication
- Premium Beauty News
- Originally published
- September 19, 2026
- Original title
- Debut unveils biotech active targeting hyperpigmentation at low use levels
- Author
- Premium Beauty News (Photo: Debut)
- Source URL
- View original ↗
Editorial Notice. This page is presented by Asia Beauty for beauty-industry news discovery and editorial reference. The original article, images, trademarks and credited materials remain attributable to their respective publisher, authors and creators. Asia Beauty is not affiliated with or endorsed by the source publisher unless explicitly stated. Content may be condensed or reformatted for consistency. Readers should consult the original publication for the definitive version. For corrections, attribution updates or removal requests, contact editorial@asiabeautymag.com.
